STOCK TITAN

Dynatronics Corporation Enters Into Purchase and Sale Agreement for Former Tennessee Site

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Dynatronics Corporation (NASDAQ:DYNT) has entered into a purchase and sale agreement with Maple Leaf Realco II, LLC, for its former manufacturing facility in Ooltewah, Tennessee. The 3.4-acre site, featuring a 54,000 sq. ft. building, is being sold for $1.75 million, with net proceeds estimated at $1.63 million. This sale follows the company's closure of Tennessee operations earlier in FY 2021 as part of cost-cutting measures. The relocation of manufacturing to New Jersey and Minnesota is aimed at enhancing operational profitability and scalability.

Positive
  • Sale of former manufacturing facility expected to net $1.63 million.
  • Cost reduction initiatives may improve operating profitability.
  • Consolidation of manufacturing is aimed at increasing scalability for growth.
Negative
  • Closure of Tennessee operations may lead to job losses.
  • Increased operational reliance on New Jersey and Minnesota may expose the company to risks associated with fewer locations.

EAGAN, MN / ACCESSWIRE / April 6, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, announced today the company entered into a purchase and sale agreement ("Agreement") with Maple Leaf Realco II, LLC for the sale of the company's former manufacturing facility in Tennessee.

The Agreement is for the sale of a 3.4 acre site with a 54,000 sq. ft. building consisting of manufacturing and office space in Ooltewah, Tennessee for a purchase price of $1.75 million USD. Completion of the sale is anticipated before the company's fiscal year end on June 30, 2021. Net proceeds for the sale are estimated to be approximately $1.63 million.

As previously announced, the company closed its operations in Tennessee in the second quarter of fiscal year 2021 as part of consolidation and cost reduction initiatives. Products manufactured by the company in Tennessee were moved to its New Jersey and Minnesota locations. These actions resulted in reduced costs, improved operating profitability, and scalability for growth.

About Dynatronics Corporation

Dynatronics Corporation is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Dynatron Solaris®, Hausmann™, Physician's Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.

Safe Harbor Notification

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Those statements include references to the company's expectations and similar statements. Such forward-looking statements reflect the views of management at the time such statements are made. These statements include our financial guidance, including uncertainties involving the impact of the COVID-19 pandemic on the company's results of operations and financial condition, our expected revenues, gross profit, and selling, general, and administrative expenses. These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in the company's annual, quarterly and other reports filed with the Securities and Exchange Commission. Dynatronics does not undertake to update its forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contacts:

Dynatronics Corporation
Investor Relations
Skyler Black
(801) 676-7201
ir@dynatronics.com

Darrow Associates
Peter Seltzberg, Managing Director
(516) 419-9915
pseltzberg@darrowir.com

For additional information, please visit: www.dynatronics.com

Connect with Dynatronics on LinkedIn

SOURCE: Dynatronics Corporation



View source version on accesswire.com:
https://www.accesswire.com/639019/Dynatronics-Corporation-Enters-Into-Purchase-and-Sale-Agreement-for-Former-Tennessee-Site

FAQ

What is the recent sale agreement made by Dynatronics Corporation?

Dynatronics has entered into a sale agreement for its former manufacturing facility in Tennessee for $1.75 million.

When is the completion date for the Dynatronics facility sale?

The sale is anticipated to complete before June 30, 2021, the company's fiscal year end.

What are the expected net proceeds from the Dynatronics facility sale?

The estimated net proceeds from the sale are approximately $1.63 million.

How will the sale of the facility impact Dynatronics Corporation?

The sale is part of a cost reduction initiative, which may improve operating profitability and allow for scalability.

DYNATRONICS CORP

OTC:DYNT

DYNT Rankings

DYNT Latest News

DYNT Stock Data

1.01M
4.11M
43.29%
0.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY